2023
DOI: 10.1080/15548627.2023.2170071
|View full text |Cite
|
Sign up to set email alerts
|

G-quadruplex ligands as potent regulators of lysosomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 106 publications
0
3
0
Order By: Relevance
“…G4 ligand induced autophagy can be a function of several pathways including cellular stress responses or lysosomal drug sequestration resulting in lysosomal membrane permeabilization 51 . For example, treatment of cervical cancer and osteosarcoma cells with G4 ligand 20A resulted in an enrichment of RNA and proteins involved in the lysosomal pathway accompanied by MTOR inhibition, global DNA damage and activation of autophagy that causes onset of senescence and protects the cell from cell death 16 , 52 .…”
Section: Discussionmentioning
confidence: 99%
“…G4 ligand induced autophagy can be a function of several pathways including cellular stress responses or lysosomal drug sequestration resulting in lysosomal membrane permeabilization 51 . For example, treatment of cervical cancer and osteosarcoma cells with G4 ligand 20A resulted in an enrichment of RNA and proteins involved in the lysosomal pathway accompanied by MTOR inhibition, global DNA damage and activation of autophagy that causes onset of senescence and protects the cell from cell death 16 , 52 .…”
Section: Discussionmentioning
confidence: 99%
“…Whether autophagy plays a role in promoting or suppressing cancer is still debated.It can either promote or inhibit the growth of malignant tumors. This suggests that autophagy may play different roles in different stages of tumorigenesis [13][14][15]. Nevertheless, the function and process of autophagy in the immune response to ovarian cancer remain uncertain.…”
Section: Introductionmentioning
confidence: 99%
“…Epigenetic abnormalities are observed at the onset and during the progression of age-related diseases, such as AD ( Cavalli and Heard, 2019 ). The global DNA methylation pattern decreases with aging and contributes to aging-associated heterochromatin loss, and some genomic regions are also characterized by age-related locus-specific hypermethylation ( Xiao et al, 2019 ; Ferret et al, 2023 ). Nevertheless, much progress has been made in understanding the genetic basis of AD in which multiple loci have been discovered.…”
Section: Introductionmentioning
confidence: 99%